Transferrin receptor: Difference between revisions
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
{{STRUCTURE_1suv| PDB=1suv | SIZE=400| SCENE= |right|CAPTION=Human transferrin receptor ectodomain dimer (grey and green) complex with transferrin N-lobe (pink and yellow) and C-lobe (cyan and magenta) and carbonate, [[1suv]] }} | {{STRUCTURE_1suv| PDB=1suv | SIZE=400| SCENE= |right|CAPTION=Human transferrin receptor ectodomain dimer (grey and green) complex with transferrin N-lobe (pink and yellow) and C-lobe (cyan and magenta) and carbonate, [[1suv]] }} | ||
== Functin == | |||
'''Transferrin receptor''' (TfR) imports iron into the cell by receptor-mediated endocytosis of [[Transferrin|transferrin]]-iron complex. TfR is regulated by intracellular iron concentration. The amount of TfR expressed on the cell is proportional to the cell’s need for iron. The TfR has selective affinity for diferric-transferrin. The TfR-transferrin complex is internalized by the cell and iron is released to the cytosol. The TfR-apotransferrin complex returns to the extracellular surface where the apotransferrin dissociates and is replaced by diferric-transferrin<ref>PMID:10192390</ref>. | |||
== Relevance == | |||
TfR is a potential determinant of iron loading in congenital anemias<ref>PMID:10468869</ref>. | |||
'''Transferrin receptor''' (TfR) imports iron into the cell by receptor-mediated endocytosis of [[Transferrin|transferrin]]-iron complex. TfR is regulated by intracellular iron concentration. The amount of TfR expressed on the cell is proportional to the cell’s need for iron. The TfR has selective affinity for diferric-transferrin. The TfR-transferrin complex is internalized by the cell and iron is released to the cytosol. The TfR-apotransferrin complex returns to the extracellular surface where the apotransferrin dissociates and is replaced by diferric-transferrin. | |||
==3D structures of transferrin receptor== | ==3D structures of transferrin receptor== | ||
Line 15: | Line 14: | ||
[[3s9l]], [[3s9m]], [[3s9n]] - hTfR ectodomain + transferrin N-lobe<br /> | [[3s9l]], [[3s9m]], [[3s9n]] - hTfR ectodomain + transferrin N-lobe<br /> | ||
[[2nsu]] - hTfR ectodomain in dog retrovirus – EM<br /> | [[2nsu]] - hTfR ectodomain in dog retrovirus – EM<br /> | ||
[[3kas]] - hTfR ectodomain + Machupo virus GP1 | [[3kas]] - hTfR ectodomain + Machupo virus GP1<br /> | ||
== References == | |||
<references/> | |||
[[Category:Topic Page]] | [[Category:Topic Page]] |
Revision as of 11:41, 21 September 2016
FunctinFunctin
Transferrin receptor (TfR) imports iron into the cell by receptor-mediated endocytosis of transferrin-iron complex. TfR is regulated by intracellular iron concentration. The amount of TfR expressed on the cell is proportional to the cell’s need for iron. The TfR has selective affinity for diferric-transferrin. The TfR-transferrin complex is internalized by the cell and iron is released to the cytosol. The TfR-apotransferrin complex returns to the extracellular surface where the apotransferrin dissociates and is replaced by diferric-transferrin[1].
RelevanceRelevance
TfR is a potential determinant of iron loading in congenital anemias[2].
3D structures of transferrin receptor3D structures of transferrin receptor
1cx8 – hTfR ectodomain – human
1de4 - hTfR ectodomain + hemochromatosis protein + β-2-microglobulin
1suv - hTfR ectodomain + transferrin
3s9l, 3s9m, 3s9n - hTfR ectodomain + transferrin N-lobe
2nsu - hTfR ectodomain in dog retrovirus – EM
3kas - hTfR ectodomain + Machupo virus GP1
ReferencesReferences
- ↑ Levy JE, Jin O, Fujiwara Y, Kuo F, Andrews NC. Transferrin receptor is necessary for development of erythrocytes and the nervous system. Nat Genet. 1999 Apr;21(4):396-9. PMID:10192390 doi:http://dx.doi.org/10.1038/7727
- ↑ Cazzola M, Beguin Y, Bergamaschi G, Guarnone R, Cerani P, Barella S, Cao A, Galanello R. Soluble transferrin receptor as a potential determinant of iron loading in congenital anaemias due to ineffective erythropoiesis. Br J Haematol. 1999 Sep;106(3):752-5. PMID:10468869